Link to Pubmed | Location | DNA nomenclature | RNA nomenclature | Protein nomenclature | Type of variant DNA | Type of variant RNA | Type of variant Protein | MAF | RS number | Biochemical evidence of pathogenicity | Splicing and translation prediction | Biochemical evidence of CRIM status | Prediction of CRIM status | Number of patients | Id | Predicted severity | Phenotype with null allele | CRIM status | Missense prediction (Mutation Taster) | Missense prediction (SIFT) | Missense prediction (Align GVGD) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PubMed | exon 2 | c.309C>G | r.(309c>g) | p.(Cys103Trp) | substitution | substitution | Substitution (missense) | MAF is less than 1% | rs373307393 | 0% residual activity in GAA expression construct | no effect on splicing | protein is expressed | 65 | Potentially less severe | Unknown | Positive | Disease causing (prob: 1) | Deleterious (score: 0.02) | Class C15 (GV: 138.77 - GD: 141.90) |
The Pompe disease GAA variant database represents an effort to collect all known variants in the GAA gene and is maintained and provide by the Pompe center, Erasmus MC. We kindly ask you to reference one of the following articles if you use this database for research purposes: de Faria, DOS, in 't Groen, SLM, Bergsma, AJ, et al. Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening. Niño, MY, in 't Groen, SLM, Hoogeveen-Westerveld, M, et al. Extension of the Pompe mutation database by linking disease‐associated variants to clinical severity. Human Mutation. 2019; 40: 1954–1967. https://doi.org/10.1002/humu.23854 |
www.pompecenter.nl |
![]() |